Mr. Breski holds over 15 years of experience in healthcare, business development, strategic consulting, and general management. Mr. Breski has been working on developing the strategy behind innovative investment models, which bring new approaches to financing in today’s healthcare environment. Previously, he served as a senior executive of business development at Rosetta Genomics, was part of the US Strategic Planning group at Novartis, and worked within Booz Allen’s Healthcare group in New York. Mr. Breski holds a B.Sc. in Biology from Tel Aviv University and an MBA from The Wharton School.